Timing of ART Makes a Difference for Those With TB
March 16, 2011 (Boston, Massachusetts) — The latest findings from the Starting Antiretroviral Therapy at Three Points in Tuberculosis (SAPIT) trial add to the weight of evidence supporting the commencement of integrated antituberculosis and antiretroviral therapy (ART) as soon as possible for patients coinfected with tuberculosis (TB) and HIV.
Blood tests could forewarn of emphysema
Screening for specific blood-borne particles or proteins might reveal whether a smoker is developing emphysema, two new studies propose, raising the possibility that a test could catch some of the millions of undiagnosed people with the condition. Both studies appear in an upcoming issue of the American Journal of Respiratory and Critical Care Medicine.
Questions Remain About Belimumab in Certain Lupus Patient Groups
March 15, 2011 — The US Food and Drug Administration (FDA) yesterday discussed belimumab (Benlysta), a newly approved drug to treat patients with active systemic lupus erythematosus (SLE), during a briefing for healthcare professionals.
Advances in Chronic Obstructive Pulmonary Disease Among Older Adults
Purpose of review This review summarizes recent research on chronic obstructive pulmonary disease (COPD) among older adults.Recent findings Recent research on COPD and older adults addresses four key areas: diagnosis and screening, comorbidities, end-of-life care, and management. These key findings include the Rotterdam study's identification of the incidence rate of COPD in older adults.